Recruiting Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors NCT07410494 Conditions Acute Myeloid Leukemia (AML), Adenocarcinoma, Adnexal Diseases, +92 more Locations District One Hospital — Beijing, Beijing Municipality, China View Trial Details
